Milana Dolezal, M.D., Oncologist and Hematologist; Medical Director of Gastrointestinal Oncology at Alta Bates Summit Comprehensive Cancer Center; East Bay Regional Research Director, Cancer Clinical Trials, Sutter Health Research Consortium

California Pacific CURRENTS: The online journal of CPMC Research Institute

Research enabling new approaches to the treatment of solid tumors and hematologic malignancies

Research Overview

  • Dr. Milana Dolezal is a board-certified internal medicine specialist, oncologist and hematologist with a focus on treating women’s malignancies (breast and gynecologic cancers) and gastrointestinal (GI) cancers.
  • A Principal Investigator and Sutter Health regional lead for National Cancer Institute (NCI) and industry-sponsored breast and GI cancer clinical trials, Dr. Dolezal investigates tumor biology and targeted cancer therapies. She participates in cancer meetings to understand the molecular and genetic pathways underlying hematological malignancies, and new treatments for patients with solid tumors.
  • Dr. Dolezal spearheads initiatives to improve genetic and molecular testing of cancer patients at Alta Bates Summit Medical Center, based on evidence-based national guidelines and quality measures.
  • She initiated a multidisciplinary cancer survivorship program in the San Francisco East Bay to improve the health and quality of life of cancer patients transitioning from treatment to recovery.
  • She leads general and GI-specific tumor boards and believes in a multi-disciplinary approach including clinical trials when appropriate, and tumor board review.

Read more about research among the Sutter Cancer Research Consortium.

Find additional information on oncology research and clinical trials at the Alta Bates Summit Comprehensive Cancer Center.


Training

Dr. Dolezal received her M.D. from Thomas Jefferson Medical College in Philadelphia. She completed residency training in internal medicine at the University of Southern California, and a fellowship in hematology-oncology at the University of California, Los Angeles School of Medicine. Her fellowship training was followed by a clinical trial/drug development fellowship at Genentech to develop targeted cancer therapies guided by tumor biology across all phases of cancer clinical trials. Prior to medical school, she worked at the NCI of the National Institutes of Health in Bethesda, Maryland and conducted research at Stanford University School of Medicine.


 

Publication Search

Publications

Natkunam Y, Soslow R, Matolcsy A, Dolezal M, Bhargava V, Knowles DM, Warnke R, Immunophenotypic and genotypic characterization of progression in follicular lymphomas. Appl Immunohistochem Mol Morphol

Milana Dolezal, M.D., Oncologist and Hematologist; Medical Director of Gastrointestinal Oncology at Alta Bates Summit Comprehensive Cancer Center; East Bay Regional Research Director, Cancer Clinical Trials, Sutter Health Research Consortium
Primary Research Interests
  • Breast and gynecologic cancers
  • GI cancers (colon, liver, pancreatic, gastric, esophageal)
  • Cancer clinical trials